GlycoNet’s Associate Director Clinical Partnerships, Dr. Lara Mahal, is bringing personalized health care to reality.
Category: Network Profile
GlycoNet Announces New Chair of the Board of Directors
Ms. Karimah Es Sabar is appointed as Chair of GlycoNet Board of Directors.
Harnessing the power of glycomics to improve drugs
Glycoscience expert Warren Wakarchuk is a Professor and Associate Scientific Director of the Canadian Glycomics Network
Glycomics researcher brings expertise and funding to UAlberta and GlycoNet
Dr. Lara Mahal, new CERC in glycomics and professor in chemistry joins GlycoNet on UAlberta campus.
Dr. Karla Williams is on a mission to change how cancer is diagnosed using glycomics
Leveraging her scientific knowledge and entrepreneurial mindset, Dr. Karla Williams is developing a blood test that could allow for early diagnosis of aggressive breast cancer.
GlycoNet awards grants worth $90,000 to three Alberta startup companies
Glyco-based companies use funds to protect intellectual property, build business capacity EDMONTON (October 9, 2018) – The Canadian Glycomics Network (GlycoNet) awarded $90,000 in grants to three Alberta-based startup companies: 48Hour Discovery Inc., GlyCa BioSciences Inc. and PanTHERA CryoSolutions Inc. The Startup Company Funding Program recognizes the needs of start-up companies and provides financial help […]
Q and A with Network Investigator Mario Monteiro, Professor, University of Guelph
What was your reaction when you were awarded the recent 2018 RBC Top 25 Immigrants Award? I think that all human beings like to be recognized for their work. I was particularly pleased in this situation in that I was being recognized for my Canadian journey so far — from high school to today. Tell us about your […]
Alberta startup to develop new diagnostics for prostate cancer
Technology bridges oncology and glycomics with discovery of novel cancer-specific sugar A new biotechnology spinoff with roots in a GlycoNet project is planning to capitalize on the discovery of a novel cancer-specific sugar to develop new diagnostic tools and drugs for prostate cancer. GlyCa BioSciences Inc. is a company based on the intellectual property developed […]
English 
French